Viral decay rate of medium- and saliva-suspended SARS-CoV-2 according to UVB exposure. by Angela Sloan (380916)

Different ellipsoidal particles with De = 6.30 mm used in the discrete element simulations. by Yongfeng Zhu (7361045)

Electrochemical, Computational, and Photophysical Characterization of New Luminescent Dirhenium–Pyridazine Complexes Containing Bridging OR or SR Anions by Alessio Raimondi (2108038)

“…A series of [Re₂(μ-ER)₂(CO)₆(μ-pydz)] complexes have been synthesized (E = S, R = C₆H₅, <b>2</b>; E = O, R = C₆F₅, <b>3</b>; C₆H₅, <b>4</b>; CH₃, and <b>5</b>; H, <b>6</b>), starting either from [Re­(CO)₅O₃SCF₃] (for <b>2</b> and <b>4</b>), [Re₂(μ-OR)₃(CO)₆]⁻ (for <b>3</b> and <b>5</b>), or [Re₄(μ₃-OH)₄(CO)₁₂] (for <b>6</b>). …”

Electrochemical, Computational, and Photophysical Characterization of New Luminescent Dirhenium–Pyridazine Complexes Containing Bridging OR or SR Anions by Alessio Raimondi (2108038)

“…A series of [Re₂(μ-ER)₂(CO)₆(μ-pydz)] complexes have been synthesized (E = S, R = C₆H₅, <b>2</b>; E = O, R = C₆F₅, <b>3</b>; C₆H₅, <b>4</b>; CH₃, and <b>5</b>; H, <b>6</b>), starting either from [Re­(CO)₅O₃SCF₃] (for <b>2</b> and <b>4</b>), [Re₂(μ-OR)₃(CO)₆]⁻ (for <b>3</b> and <b>5</b>), or [Re₄(μ₃-OH)₄(CO)₁₂] (for <b>6</b>). …”

Table 2_Cost-effectiveness of the 3E model in diabetes management: a machine learning approach to assess long-term economic impact.docx by Supriya Raghav (21412907)

“…</p>Methods<p>We conducted an observational longitudinal descriptive analysis involving 320 patients, who were grouped into intervention and control groups over a 24-month period.</p>Results<p>The 3E model demonstrated significant cost reductions, with the intervention group achieving a 74.3% decrease in total costs compared to 41.8% in the control group while maintaining the same level of glycemic control. …”

Table 1_Cost-effectiveness of the 3E model in diabetes management: a machine learning approach to assess long-term economic impact.xlsx by Supriya Raghav (21412907)

“…</p>Methods<p>We conducted an observational longitudinal descriptive analysis involving 320 patients, who were grouped into intervention and control groups over a 24-month period.</p>Results<p>The 3E model demonstrated significant cost reductions, with the intervention group achieving a 74.3% decrease in total costs compared to 41.8% in the control group while maintaining the same level of glycemic control. …”

Results of final piece-wise LGCM for assessing the concurrent effect of predictors on changes in EQ-5D-5L summary score (<i>n </i>= 1071). by Somayeh Momenyan (10111603)

Fig 2 - by Ian J. Aitkenhead (8787518)

Modeled concentrations (mg/kg dry weight) of lead (Pb) in <i>Hylocomium splendens</i> moss tissue in 2006 and 2017, average change, percent change, and probability of decrease for... by Peter N. Neitlich (4034300)

“…Results are presented for the posterior mean, standard deviation (SD), and the lower and upper bounds representing the 2.5% and 97.5% endpoints of the 95% credible interval. …”

Modeled concentrations (mg/kg dry weight) of zinc (Zn) in <i>Hylocomium splendens</i> moss tissue in 2006 and 2017, average change, percent change, and probability of decrease for... by Peter N. Neitlich (4034300)

“…Results are presented for the posterior mean, standard deviation (SD), and the lower and upper bounds representing the 2.5% and 97.5% endpoints of the 95% credible interval. …”

Modeled concentrations (mg/kg dry weight) of cadmium (Cd) in <i>Hylocomium splendens</i> moss tissue in 2006 and 2017, average change, percent change, and probability of decrease f... by Peter N. Neitlich (4034300)

“…Results are presented for the posterior mean, standard deviation (SD), and the lower and upper bounds representing the 2.5% and 97.5% endpoints of the 95% credible interval. …”

9 mo Pkd2+/- mice have enhanced responses to acute ISO application. by Ivana Y. Kuo (707543)

Primary and secondary outcomes of the randomized clinical trial groups at 3 months and 12 months. by Teemu P. Hevonkorpi (11577571)

Subjects:

Baseline characteristics of 291 patients by randomization group. by Teemu P. Hevonkorpi (11577571)

Subjects:

Adverse events at 12-month follow-up by study group. by Teemu P. Hevonkorpi (11577571)

Subjects:

Participant flow diagram of the DRIFT trial. by Teemu P. Hevonkorpi (11577571)

Subjects:

Between-group differences of mean PRWE with 95% confidence intervals in primarily malaligned DRFs and early malaligned DRFs at 3-month and 12-month follow-up. by Teemu P. Hevonkorpi (11577571)

Subjects:

OCP vs. time curves for P110 carbon steel corrosion in the absence and presence of different concentrations of (a) 5, (b) 6a and (c) 6b. by Ghadeer Mubarak (21567569)

GON-1 acts for insulin signaling at peripheral tissues. by Sawako Yoshina (375229)

Proportion of emergent synchronization patterns along cross-sectional age ( participants for each age group) for five different cognitive systems. by Andrew Patton (10224161)